Abstract

AbstractThe control of the duration of macular edema is a key‐factor to prevent irreversible neuro‐retinal lesions. Pharmacological studies have demonstrated the interest of early intravitreal treatments (either anti‐VEGF or dexamethasone) to control vascular macular edema, especially in diabetic macular edema and retinal vein occlusions. However, in some cases, pharmacological therapy fails to control retinal exudation, either at once or after a while. The remodeling of the retinal capillary network secondary to chronic vascular disturbances can indeed maintain the exudation. Telangiectatic capillaries is one of modifications of the vascular network that can be involved in persistent or recurrent vascular edema. TelCaps may be identified on the fundus as dark‐reddish round lesions often with white borders. They may be either isolated or gathered in clusters. In some cases, however, TelCaps remain barely visible. ICG‐angiography remains the most efficient imaging mode for TelCaps detection, enabling to precise their number and location towards the fovea. Our presentation will focus on clinical presentations of such TelCaps in vascular diseases: diabetic retinopathy, retinal vein occlusions, Coats’ disease. Both management and outcomes will be discussed.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call